Home/Filings/4/0002001011-25-000123
4//SEC Filing

Espinoza Octavio 4

Accession 0002001011-25-000123

CIK 0000886163other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 8:06 PM ET

Size

4.7 KB

Accession

0002001011-25-000123

Insider Transaction Report

Form 4
Period: 2025-12-05
Espinoza Octavio
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-12-05$184.87/sh1,862$344,22827,990 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001905248

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 8:06 PM ET
Size
4.7 KB